Key result
Recent technological advancements have uncovered a vast array of tumor vascular bed-specific markers that may provide a platform for new cancer diagnostics and therapeutics.
This review highlights the potential of tumor vascular biomarkers for developing new cancer diagnostics and therapeutics.
Tumor vascular markers remain investigational; leaves open their diagnostic and therapeutic utility pending prospective validation.
Tumor vasculature varies significantly from its normal counterpart and displays unique markers. Recent technological advancements including immunohistochemistry laser-capture microdissection (immuno-LCM), genome-wide high-throughput screening, and proteomics have uncovered a vast array of vascular bed-specific markers that may provide a platform for discovery of new therapeutics directed against various malignancies. However, an essential step in the translation of these markers to clinical application will be the identification of those biomarkers with the highest diagnostic and therapeutic potential. The aim of the current review is to provide a synopsis of recent advancements in the identification of tumor vasculature biomarkers.
No takes yet. Share an insight, caveat, or question.
Li et al. (2011) conducted a review in Cancer. Tumor vasculature biomarkers was evaluated. Recent technological advancements have uncovered a vast array of tumor vascular bed-specific markers that may provide a platform for new cancer diagnostics and therapeutics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: